SCHEMBL2364037

SCHEMBL2364037

CCC(=O)Nc1cc(C(=O)Sc2cc(OC)c(OC)c(OC)c2)ccc1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.49
MAPK1 P28482 1/20 0.49
AHR P35869 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HTT P42858 2/20 0.48
KMT2A Q03164 5/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
LMNA P02545 4/20 0.47
ALDH1A1 P00352 3/20 0.47
MEN1 O00255 2/20 0.45
NPC1 O15118 1/20 0.45
LTB4R Q15722 2/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
NPSR1 Q6W5P4 1/20 0.43
TUBB4A P04350 1/20 0.42
TUBB P07437 1/20 0.42
TUBA3C P0DPH7 1/20 0.42
TUBA1B P68363 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17507545 0.91 ALDH1A1 (0.49) MAPTMAPK1AHRSMN1; SMN2HTT
SCHEMBL17507492 0.90 KMT2A (0.46) MAPTMAPK1AHRSMN1; SMN2HTT
SCHEMBL12435912 0.89 HTT (0.44) MAPTMAPK1AHRSMN1; SMN2HTT
SCHEMBL17507543 0.86 MAPT (0.50) MAPTHTTKMT2ALMNAALDH1A1
SCHEMBL2217242 0.81 MAPT (0.56) MAPTMAPK1AHRSMN1; SMN2HTT
SCHEMBL2359445 0.81 LMNA (0.47) MAPTMAPK1SMN1; SMN2HTTKMT2A
SCHEMBL17507529 0.81 LMNA (0.47) MAPTMAPK1SMN1; SMN2HTTKMT2A
SCHEMBL2215369 0.81 MAPT (0.49) MAPTMAPK1AHRSMN1; SMN2HTT
SCHEMBL17507493 0.81 HTT (0.51) MAPTMAPK1AHRSMN1; SMN2HTT
SCHEMBL17507533 0.80 ALDH1A1 (0.46) MAPTSMN1; SMN2HTTKMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2351731-B1 A GROUP OF AMINO SUBSTITUTED BENZOYL DERIVATIVES AND THEIR PREPARATION AND THEIR USE INST MED BIOTECHNOLOGY CAMS (CN) 2016-02-10 EP disclosed
US-8710098-B2 Group of amino substituted benzoyl derivatives and their preparation and their use Institute of Medicinal Biotechnology Chinese Academy of Medical Science (CN) 2014-04-29 US disclosed
EP-2351731-A1 A GROUP OF AMINO SUBSTITUTED BENZOYL DERIVATIVES AND THEIR PREPARATION AND THEIR USE Institute Of Medicinal Biotechnology, Chinese Academy of Medical Sciences (CN) 2011-08-03 EP disclosed
US-20110178108-A1 Group of amino substituted benzoyl derivatives and their preparation and their use Institute of Medicinal Biotechnology Academy of Medical Science (CN) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178108-A1 Group of amino substituted benzoyl derivatives and their preparation and their use CUL3, APOBEC3G, BRPF3 MAPT 3474/4885MAPK1 4279/4885AHR 2192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.